Clinical data | |
---|---|
Trade names | Coactin, Leo, Selexid, Selexidin |
AHFS/Drugs.com | International Drug Names |
Pregnancy category |
|
Routes of administration | Intravenous, intramuscular |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | Negligible |
Protein binding | 5 to 10% |
Metabolism | Some hepatic metabolism |
Elimination half-life | 1 to 3 hours |
Excretion | Renal and biliary, mostly unchanged |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.046.601 |
Chemical and physical data | |
Formula | C15H23N3O3S |
Molar mass | 325.43 g·mol−1 |
3D model (JSmol) | |
| |
(what is this?) (verify) |
Mecillinam (INN) or amdinocillin (USAN) is an extended-spectrum penicillin antibiotic of the amidinopenicillin class that binds specifically to penicillin binding protein 2 (PBP2),[2] and is only considered to be active against Gram-negative bacteria. It is used primarily in the treatment of urinary tract infections, and has also been used to treat typhoid and paratyphoid fever.[3][4] Because mecillinam has very low oral bioavailability, an orally active prodrug was developed: pivmecillinam.